Osemitamab in combination with capecitabine and oxaliplatin (CAPOX) as a first line treatment of advanced G/GEJ cancer: Updated data of cohort C from a phase I/IIa, multi-center study (TranStar102/TST001-1002).Lin Shen, Caroline Germa, Ning Li et al.|Journal of Clinical Oncology|2023Cited by 16